Detalhe da pesquisa
1.
Detection of chromosomal alteration after infusion of gene-edited allogeneic CAR T cells.
Mol Ther
; 31(3): 676-685, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36518079
2.
Fludarabine and neurotoxicity in engineered T-cell therapy.
Gene Ther
; 25(3): 176-191, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29789639
3.
Predictive genomic biomarkers.
Curr Top Microbiol Immunol
; 355: 173-88, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-21877260
4.
Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase 3 trials.
Lancet Oncol
; 13(8): 827-37, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22759480
5.
Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer.
J Clin Oncol
; 41(18): 3278-3286, 2023 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37315390
6.
Transarterial chemoembolization plus or minus intravenous bevacizumab in the treatment of hepatocellular cancer: a pilot study.
BMC Cancer
; 12: 16, 2012 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-22244160
7.
From XenoMouse technology to panitumumab, the first fully human antibody product from transgenic mice.
Nat Biotechnol
; 25(10): 1134-43, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17921999
8.
An open-label clinical trial evaluating safety and pharmacokinetics of two dosing schedules of panitumumab in patients with solid tumors.
Clin Colorectal Cancer
; 8(1): 29-37, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19203894
9.
Targeting vascular endothelial growth factor with the monoclonal antibody bevacizumab inhibits human hepatocellular carcinoma cells growing in an orthotopic mouse model.
Liver Int
; 29(2): 284-90, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18482274
10.
Triple-drug transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma: assessment of survival in 124 consecutive patients.
AJR Am J Roentgenol
; 193(6): 1665-71, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19933662
11.
Dose and schedule study of panitumumab monotherapy in patients with advanced solid malignancies.
Clin Cancer Res
; 14(2): 502-8, 2008 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18223225
12.
Long-term safety and activity of NY-ESO-1 SPEAR T cells after autologous stem cell transplant for myeloma.
Blood Adv
; 3(13): 2022-2034, 2019 07 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31289029
13.
Systemic and local immunity following adoptive transfer of NY-ESO-1 SPEAR T cells in synovial sarcoma.
J Immunother Cancer
; 7(1): 276, 2019 10 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-31651363
14.
Association of K-ras mutational status and clinical outcomes in patients with metastatic colorectal cancer receiving panitumumab alone.
Clin Colorectal Cancer
; 7(3): 184-90, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18621636
15.
Antitumor Activity Associated with Prolonged Persistence of Adoptively Transferred NY-ESO-1 c259T Cells in Synovial Sarcoma.
Cancer Discov
; 8(8): 944-957, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29891538
16.
Panitumumab with irinotecan/leucovorin/5-fluorouracil for first-line treatment of metastatic colorectal cancer.
Clin Colorectal Cancer
; 6(6): 427-32, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17531105
17.
Darbepoetin alfa for the treatment of chemotherapy-induced anemia: disease progression and survival analysis from four randomized, double-blind, placebo-controlled trials.
J Clin Oncol
; 23(28): 6941-8, 2005 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16192582
18.
Anti-human immunodeficiency virus hematopoietic progenitor cell-delivered ribozyme in a phase I study: myeloid and lymphoid reconstitution in human immunodeficiency virus type-1-infected patients.
Hum Gene Ther
; 15(3): 251-62, 2004 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-15018734
19.
Clinical gene therapy research utilizing ribozymes: application to the treatment of HIV/AIDS.
Methods Mol Biol
; 252: 581-98, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15017082
20.
Critical steps in the implementation of hematopoietic progenitor-cell gene therapy using ribozyme vectors: a laboratory protocol.
Methods Mol Biol
; 252: 599-616, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15017083